| |
| |
|
| Insider
Information: |
Mueller Brian |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
81,859 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,368,863 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
81,859 |
|
|
| Total
Value |
$6,368,863 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Financial O... |
2024-03-15 |
71,859 |
|
0 |
Premium* |
|
|
Anthera Pharmaceuticals Inc |
ANTH |
|
2015-12-23 |
10,000 |
2015-12-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
136 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2021-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,110 |
38,800 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2021-04-30 |
4 |
A |
$62.41 |
$21,281 |
D/D |
341 |
31,357 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,040 |
40,749 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
24,890 |
52,636 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,630 |
62,266 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2024-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
35,125 |
81,248 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2024-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,400 |
92,648 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-07-02 |
4 |
AS |
$40.00 |
$110,800 |
D/D |
(2,770) |
15,340 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-07-10 |
4 |
AS |
$42.50 |
$106,250 |
D/D |
(2,500) |
15,340 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-11-05 |
4 |
AS |
$46.00 |
$376,250 |
D/D |
(8,000) |
15,340 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-11-15 |
4 |
AS |
$50.00 |
$790,600 |
D/D |
(15,812) |
15,340 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2016-08-01 |
4 |
AS |
$100.00 |
$28,700 |
D/D |
(287) |
14,260 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2017-05-08 |
4 |
AS |
$91.17 |
$687,334 |
D/D |
(7,482) |
13,468 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2017-06-22 |
4 |
AS |
$100.00 |
$267,100 |
D/D |
(2,671) |
12,885 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2018-05-10 |
4 |
AS |
$89.50 |
$219,275 |
D/D |
(2,450) |
15,396 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2018-06-15 |
4 |
AS |
$94.50 |
$190,985 |
D/D |
(2,021) |
13,029 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2018-06-22 |
4 |
AS |
$99.50 |
$312,928 |
D/D |
(3,145) |
12,375 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2018-08-07 |
4 |
AS |
$104.50 |
$261,250 |
D/D |
(2,500) |
12,375 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2019-04-05 |
4 |
AS |
$94.00 |
$277,582 |
D/D |
(2,953) |
13,660 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2021-04-01 |
4 |
AS |
$76.30 |
$434,300 |
D/D |
(5,692) |
31,016 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2021-05-07 |
4 |
AS |
$79.50 |
$533,366 |
D/D |
(6,709) |
31,357 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-07-08 |
4 |
AS |
$89.50 |
$656,662 |
D/D |
(7,337) |
30,726 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-08-05 |
4 |
AS |
$94.50 |
$330,750 |
D/D |
(3,500) |
30,726 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-11-23 |
4 |
AS |
$95.09 |
$531,092 |
D/D |
(5,379) |
28,847 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-12-02 |
4 |
AS |
$104.50 |
$731,605 |
D/D |
(7,001) |
27,746 |
0 |
- |
|
136 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
